Custom inducible knockin mouse

Closed Pre-Solicitation Posted

Solicitation number
PCA-NIDDK-02527
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health intends to award a Firm-Fixed-Price Purchase Order for custom inducible knockin mouse generation services by approximately September 1, 2026, under a sole-source justification to Ingenious Targeting Laboratory Inc.

The Government determined that while CRISPR/Cas9 and custom mouse-model generation services are available from multiple sources, the specific requirement—endogenous Gcm2 genomic modification—is satisfied only by Ingenious Targeting Laboratory Inc. Alternative services offering Gcm2 expression through heterologous promoters in transgenes do not meet the technical requirement because they do not modify the endogenous Gcm2 gene itself. Market research identified no other responsible source capable of satisfying the complete technical requirement for this precision genomic-editing application.

This notice is not a request for competitive quotes. However, small businesses across all categories—including 8(a), service-disabled veteran owned, HUBZone, small disadvantaged, veteran-owned, and women-owned small businesses—may submit a written capability statement demonstrating their ability to perform the requirement. The Government retains sole discretion to compete the award based on responses received.

Award is anticipated approximately five business days after notice issuance unless the Government determines that another vendor possesses the required capability. Work falls under NAICS 541714 (Research and Development in Biotechnology) and PSC 6505 (Drugs and Biologicals).

Notice text

Notice of Intent: CUSTOM INDUCIBLE KNOCKIN MOUSE

                           (PCA-NIDDK-02527)

The National Institutes of Health intends to award a Firm-Fixed-Price Purchase Order to  Ingenious Targeting Laboratory Inc.

In accordance with FAR Part 6.302-1, Ingenious Targeting Laboratory Inc is the only responsible source presently identified as capable of satisfying the complete technical requirements of this Custom Inducible Knockin Mouse.

The Government determined that CRISPR/Cas9 and custom mouse-model generation services are available from multiple sources. However, the Government's requirement is for a specific endogenous Gcm2 genomic modification, rather than generic CRISPR/Cas9 mouse generation.

Alternative services offering Gcm2 expression through a heterologous promoter in a transgene do not satisfy this requirement because they do not modify the endogenous Gcm2 gene.

Based on the market research conducted to date, Ingenious Targeting Laboratory Inc. is the only responsible source identified as capable of satisfying the Government's complete technical requirement.

This notice is not a request for competitive quotes.  Ingenious Targeting Laboratory Inc. is the provider of CRISPR/Cas9 precision genomic-editing services specifically suited to the generation of the required Gcm2 knock-in mouse line this service.  However, any available small businesses (e.g., 8(a), service-disabled veteran owned small business, HUBZone small business, small disadvantaged business, veteran-owned small business, and women-owned small business) as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement. A determination by the Government to compete this proposed award based upon responses to this notice is solely within the discretion of the Government.

It is anticipated that an award will be issued approximately five (5) days after the date of this notice unless the Government determines that another vendor has the capability to meet this requirement.

Please email responses to vensonm@mail.nih.gov no later than 09:00 a.m.  EDT on September 01, 2026.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR Bethesda, Maryland 20892, United States · NAICS 541380 Office of Logisitics and Acquisition Operations No set-aside
NOI - A Non-Invasive Prognostic Biomarker - Circul NAICS 541380 Office of Logisitics and Acquisition Operations No set-aside
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Intent to Sole Source - Fertility Preservation Lab Services Bethesda, Maryland 20892, United States · NAICS 621410 National Institutes of Health No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity